Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Doxorubicin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 39 Breast Neoplasms 27 Lymphoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Sarcoma 21 Hodgkin Disease 20 Burkitt Lymphoma 20 Triple Negative Breast Neoplasms 18 Lymphoma, Follicular 14 Lymphoma, B-Cell 13 Ovarian Neoplasms 11 Neoplasms 10 Lymphoma, Non-Hodgkin 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 8 Lymphoma, Mantle-Cell 8 Endometrial Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, B-Cell, Marginal Zone 6 Liposarcoma 6 Leukemia 6 Recurrence 5 Osteosarcoma 5 Neuroblastoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leiomyosarcoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma, Ewing 4

Interventions

Cisplatin 5 pembrolizumab 4 durvalumab 4 Pemetrexed 4 palbociclib 3 Nivolumab 3 Fulvestrant 3 Carboplatin 3 Anastrozole 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 pralsetinib 2 cobimetinib 2 atezolizumab 2 abemaciclib 2 Vemurafenib 2 Radiosurgery 2 Paclitaxel 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 Bevacizumab 2 Ascorbic Acid 2 AZD9833 2 trametinib 1 taletrectinib 1 spartalizumab 1 sotorasib 1 repotrectinib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡